{"transactions":[{"id":1590252,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2024-03-07T16:24:19.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":55226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on January 30, 2024 pursuant to the satisfaction of performance criteria and vested on March 5, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":55226},"source":{"system":"sec-edgar","filing":"0000950170-24-028002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024028002/ownership.xml","form_type":"4"}},{"id":1590251,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2024-03-07T16:24:19.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022, March 5, 2023, March 5, 2024 and 22,576 vesting on March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022, March 5, 2023, March 5, 2024 and 22,576 vesting on March 5, 2025."}],"balance_after":22576,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0000950170-24-028002","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024028002/ownership.xml","form_type":"4"}},{"id":1590250,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-03-07T16:24:19.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":55226,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount reflects the sale of 9,815 Ordinary Shares by the Reporting Person, as reported in a Form 4 filed on March 1, 2024, which was inadvertently omitted from the amount of securities beneficially owned by the Reporting Person following the transactions reported in a Form 4 filed on March 5, 2024."}],"balance_after":145915,"source":{"system":"sec-edgar","filing":"0000950170-24-028002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024028002/ownership.xml","form_type":"4"}},{"id":1590249,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-03-07T16:24:19.000Z","date":"2024-03-05","kind":"exercise","planned":true,"acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Amount reflects the sale of 9,815 Ordinary Shares by the Reporting Person, as reported in a Form 4 filed on March 1, 2024, which was inadvertently omitted from the amount of securities beneficially owned by the Reporting Person following the transactions reported in a Form 4 filed on March 5, 2024."}],"balance_after":90689,"source":{"system":"sec-edgar","filing":"0000950170-24-028002","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024028002/ownership.xml","form_type":"4"}},{"id":1600393,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2024-03-05T16:25:00.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023 and March 4, 2024, and 33,512 vesting on each of March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":67024,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0000950170-24-025995","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024025995/ownership.xml","form_type":"4"}},{"id":1600392,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2024-03-05T16:25:00.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":false,"shares":24900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":74701,"derivative":{"underlying":"Ordinary Shares","underlying_shares":24900},"source":{"system":"sec-edgar","filing":"0000950170-24-025995","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024025995/ownership.xml","form_type":"4"}},{"id":1600391,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-03-05T16:25:00.000Z","date":"2024-03-04","kind":"exercise","planned":true,"acquired":true,"shares":33512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":77928,"source":{"system":"sec-edgar","filing":"0000950170-24-025995","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024025995/ownership.xml","form_type":"4"}},{"id":1600390,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-03-05T16:25:00.000Z","date":"2024-03-03","kind":"exercise","planned":true,"acquired":true,"shares":24900,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":44416,"source":{"system":"sec-edgar","filing":"0000950170-24-025995","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024025995/ownership.xml","form_type":"4"}},{"id":1608811,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2024-03-01T06:45:58.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":false,"shares":19515,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 19,514 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 19,515 vested on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 19,514 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 19,515 vested on February 28, 2024."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19515},"source":{"system":"sec-edgar","filing":"0000950170-24-023524","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024023524/ownership.xml","form_type":"4"}},{"id":1608810,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-03-01T06:45:58.000Z","date":"2024-02-28","kind":"sale","planned":true,"acquired":false,"shares":9815,"price":13.116,"value":128733.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 13, 2023."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.19, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":9701,"source":{"system":"sec-edgar","filing":"0000950170-24-023524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024023524/ownership.xml","form_type":"4"}},{"id":1608809,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-03-01T06:45:58.000Z","date":"2024-02-28","kind":"exercise","planned":true,"acquired":true,"shares":19515,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":19516,"source":{"system":"sec-edgar","filing":"0000950170-24-023524","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024023524/ownership.xml","form_type":"4"}},{"id":1631351,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2024-02-21T07:37:43.000Z","date":"2024-02-16","kind":"sale","planned":false,"acquired":false,"shares":173261,"price":13.0549,"value":2261905.0289,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.01 to $13.15, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"Number of shares rounded to the nearest whole share."}],"balance_after":1,"source":{"system":"sec-edgar","filing":"0000950170-24-017567","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024017567/ownership.xml","form_type":"4"}},{"id":1664422,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2024-02-01T07:22:53.000Z","date":"2024-01-30","kind":"grant","planned":false,"acquired":true,"shares":55226,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on March 5, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":55226,"derivative":{"underlying":"Ordinary Shares","underlying_shares":55226},"source":{"system":"sec-edgar","filing":"0000950170-24-009612","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000095017024009612/ownership.xml","form_type":"4"}},{"id":1964421,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-08T16:04:28.000Z","date":"2023-03-07","kind":"sale","acquired":false,"shares":4699,"price":9.4279,"value":44301.7021,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units reported under Table II of the Form 4 filed by the reporting person with the SEC on March 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.37 to $9.725, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":173262,"source":{"system":"sec-edgar","filing":"0001209191-23-017157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123017157/doc4.xml","form_type":"4"}},{"id":1964420,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-08T16:04:28.000Z","date":"2023-03-06","kind":"sale","acquired":false,"shares":1566,"price":9.9309,"value":15551.7894,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F3","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units reported under Table II of the Form 4 filed by the reporting person with the SEC on March 7, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $10.045, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":177961,"source":{"system":"sec-edgar","filing":"0001209191-23-017157","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123017157/doc4.xml","form_type":"4"}},{"id":1967366,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-05","kind":"exercise","acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022 and March 5, 2023, and 22,576 vesting on each of March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 5, 2021, with 22,576 vested on March 5, 2022 and March 5, 2023, and 22,576 vesting on each of March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":45152,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1967365,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":33512,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Restricted share units were granted on March 4, 2022, with 33,512 vested on March 4, 2023, and 33,512 vesting on each of March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":100536,"derivative":{"underlying":"Ordinary Shares","underlying_shares":33512},"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1967364,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-04","kind":"exercise","acquired":false,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 11,940 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"Restricted share units were granted on March 4, 2019, with 11,940 vested on each of March 4, 2021, March 4, 2022, and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1967363,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-03","kind":"grant","acquired":true,"shares":99601,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Restricted share units were granted on March 3, 2023, with 24,900 vesting on each of March 3, 2024, March 3, 2025 and March 3, 2026, and 24,901 vesting on March 3, 2027."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":99601,"derivative":{"underlying":"Ordinary Shares","underlying_shares":99601},"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1967362,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-05","kind":"exercise","acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":179527,"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1967361,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":33512,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":156951,"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1967360,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-07T16:05:15.000Z","date":"2023-03-04","kind":"exercise","acquired":true,"shares":11940,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":123439,"source":{"system":"sec-edgar","filing":"0001209191-23-016690","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123016690/doc4.xml","form_type":"4"}},{"id":1981835,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-03-02T07:34:41.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":47598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on February 7, 2023 pursuant to the satisfaction of performance criteria and vested on February 28, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":47598},"source":{"system":"sec-edgar","filing":"0001209191-23-014437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123014437/doc4.xml","form_type":"4"}},{"id":1981834,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-03-02T07:34:41.000Z","date":"2023-02-28","kind":"exercise","acquired":false,"shares":19514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 19,514 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 19,515 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 19,514 vested on each of February 28, 2021, February 28, 2022 and February 28, 2023, and 19,515 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":19515,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19514},"source":{"system":"sec-edgar","filing":"0001209191-23-014437","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123014437/doc4.xml","form_type":"4"}},{"id":1981833,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-02T07:34:41.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":23888,"price":9.8866,"value":236171.1008,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.94, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":111499,"source":{"system":"sec-edgar","filing":"0001209191-23-014437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123014437/doc4.xml","form_type":"4"}},{"id":1981832,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-02T07:34:41.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":47598,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":135387,"source":{"system":"sec-edgar","filing":"0001209191-23-014437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123014437/doc4.xml","form_type":"4"}},{"id":1981831,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-02T07:34:41.000Z","date":"2023-02-28","kind":"sale","acquired":false,"shares":9797,"price":9.8866,"value":96859.0202,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.86 to $9.94, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":87789,"source":{"system":"sec-edgar","filing":"0001209191-23-014437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123014437/doc4.xml","form_type":"4"}},{"id":1981830,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2023-03-02T07:34:41.000Z","date":"2023-02-28","kind":"exercise","acquired":true,"shares":19514,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":97586,"source":{"system":"sec-edgar","filing":"0001209191-23-014437","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123014437/doc4.xml","form_type":"4"}},{"id":2025668,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2023-02-09T07:03:22.000Z","date":"2023-02-07","kind":"grant","acquired":true,"shares":47598,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 28, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":47598,"derivative":{"underlying":"Ordinary Shares","underlying_shares":47598},"source":{"system":"sec-edgar","filing":"0001209191-23-007951","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919123007951/doc4.xml","form_type":"4"}},{"id":2346106,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-05","kind":"exercise","acquired":false,"shares":22576,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F10","text":"Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F10","text":"Restricted share units were granted on March 5, 2021, with 22,576 having vested on March 5, 2022 and 22,576 vesting on each of March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":67728,"derivative":{"underlying":"Ordinary Shares","underlying_shares":22576},"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346105,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"grant","acquired":true,"shares":134048,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Restricted share units were granted on March 4, 2022, with 33,512 vesting on each of March 4, 2023, March 4, 2024, March 4, 2025 and March 4, 2026."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":134048,"derivative":{"underlying":"Ordinary Shares","underlying_shares":134048},"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346104,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on March 4, 2019, with 11,940 having vested on each of March 4, 2021 and March 4, 2022, and 11,940 vesting on March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on March 4, 2019, with 11,940 having vested on each of March 4, 2021 and March 4, 2022, and 11,940 vesting on March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":11940,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346103,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"exercise","acquired":false,"shares":32518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were received on February 8, 2022 upon satisfaction of performance criteria and vested on March 4, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":32518},"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346102,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-07","kind":"sale","acquired":false,"shares":11334,"price":7.3667,"value":83494.1778,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.30 to $7.49, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":78072,"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346101,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-05","kind":"exercise","acquired":true,"shares":22576,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":89406,"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346100,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":6301,"price":7.4825,"value":47147.2325,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":66830,"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346099,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":11940,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":73131,"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346098,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"sale","acquired":false,"shares":17157,"price":7.4825,"value":128377.2525,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":61191,"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2346097,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-08T16:05:35.000Z","date":"2022-03-04","kind":"exercise","acquired":true,"shares":32518,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":78348,"source":{"system":"sec-edgar","filing":"0001209191-22-017039","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122017039/doc4.xml","form_type":"4"}},{"id":2363113,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-03-02T07:45:30.000Z","date":"2022-02-28","kind":"exercise","acquired":false,"shares":19514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020, with 19,514 having vested on each of February 28, 2021 and February 28, 2022, 19,514 vesting on February 28, 2023, and 19,515 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020, with 19,514 having vested on each of February 28, 2021 and February 28, 2022, 19,514 vesting on February 28, 2023, and 19,515 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":39029,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19514},"source":{"system":"sec-edgar","filing":"0001209191-22-014468","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122014468/doc4.xml","form_type":"4"}},{"id":2363112,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-02T07:45:30.000Z","date":"2022-02-28","kind":"sale","acquired":false,"shares":9797,"price":8.1422,"value":79769.1334,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.035 to $8.255,\ninclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full\ninformation regarding the number of shares sold at each separate price."}],"balance_after":45830,"source":{"system":"sec-edgar","filing":"0001209191-22-014468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122014468/doc4.xml","form_type":"4"}},{"id":2363111,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-03-02T07:45:30.000Z","date":"2022-02-28","kind":"exercise","acquired":true,"shares":19514,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":55627,"source":{"system":"sec-edgar","filing":"0001209191-22-014468","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122014468/doc4.xml","form_type":"4"}},{"id":2405316,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-02-10T16:08:25.000Z","date":"2022-02-08","kind":"grant","acquired":true,"shares":32518,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on March 4, 2022."}],"balance_after":32518,"derivative":{"underlying":"Ordinary Shares","underlying_shares":32518},"source":{"system":"sec-edgar","filing":"0001209191-22-008413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122008413/doc4.xml","form_type":"4"}},{"id":2405315,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2022-02-10T16:08:25.000Z","date":"2022-02-09","kind":"exercise","acquired":false,"shares":6568,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 6,567 having vested on each of February 9, 2020 and February 9, 2021 and\n6,568 having vested on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 6,567 having vested on each of February 9, 2020 and February 9, 2021 and\n6,568 having vested on February 9, 2022."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6568},"source":{"system":"sec-edgar","filing":"0001209191-22-008413","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122008413/doc4.xml","form_type":"4"}},{"id":2405314,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-02-10T16:08:25.000Z","date":"2022-02-09","kind":"sale","acquired":false,"shares":3583,"price":9.0605,"value":32463.7715,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting\nof the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $9.06 to $9.075, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":36113,"source":{"system":"sec-edgar","filing":"0001209191-22-008413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122008413/doc4.xml","form_type":"4"}},{"id":2405313,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2022-02-10T16:08:25.000Z","date":"2022-02-09","kind":"exercise","acquired":true,"shares":6568,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":39696,"source":{"system":"sec-edgar","filing":"0001209191-22-008413","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919122008413/doc4.xml","form_type":"4"}},{"id":2697818,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-05-25T08:41:05.000Z","date":"2021-05-21","kind":"sale","acquired":false,"shares":40000,"price":11.008,"value":440320.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F2","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.00 to $11.04, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":33128,"source":{"system":"sec-edgar","filing":"0001209191-21-035605","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121035605/doc4.xml","form_type":"4"}},{"id":2715490,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-05-13T07:44:06.000Z","date":"2021-05-11","kind":"exercise","acquired":false,"shares":37884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 9, 2021 pursuant to the satisfaction of performance criteria and vested on May 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 9, 2021 pursuant to the satisfaction of performance criteria and vested on May 11, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37884},"source":{"system":"sec-edgar","filing":"0001209191-21-032251","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121032251/doc4.xml","form_type":"4"}},{"id":2715489,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-05-13T07:44:06.000Z","date":"2021-05-11","kind":"sale","acquired":false,"shares":19804,"price":10.2208,"value":202412.7232,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.2206 to $10.2300, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":73128,"source":{"system":"sec-edgar","filing":"0001209191-21-032251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121032251/doc4.xml","form_type":"4"}},{"id":2715488,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-05-13T07:44:06.000Z","date":"2021-05-11","kind":"exercise","acquired":true,"shares":37884,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":92932,"source":{"system":"sec-edgar","filing":"0001209191-21-032251","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121032251/doc4.xml","form_type":"4"}},{"id":2804406,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-03-08T16:04:10.000Z","date":"2021-03-05","kind":"grant","acquired":true,"shares":90304,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on March 5, 2021, with 22,576 vesting on each of March 5, 2022, March 5, 2023, March 5, 2024 and March 5, 2025."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":90304,"derivative":{"underlying":"Ordinary Shares","underlying_shares":90304},"source":{"system":"sec-edgar","filing":"0001209191-21-018512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121018512/doc4.xml","form_type":"4"}},{"id":2804405,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-03-08T16:04:10.000Z","date":"2021-03-04","kind":"exercise","acquired":false,"shares":11940,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on March 4, 2019, with 11,940 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on March 4, 2019, with 11,940 vesting on each of March 4, 2021, March 4, 2022 and March 4, 2023."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":23880,"derivative":{"underlying":"Ordinary Shares","underlying_shares":11940},"source":{"system":"sec-edgar","filing":"0001209191-21-018512","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121018512/doc4.xml","form_type":"4"}},{"id":2804404,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-03-08T16:04:10.000Z","date":"2021-03-04","kind":"sale","acquired":false,"shares":6183,"price":10.5844,"value":65443.3452,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.510 to $10.700, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":55048,"source":{"system":"sec-edgar","filing":"0001209191-21-018512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121018512/doc4.xml","form_type":"4"}},{"id":2804403,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-03-08T16:04:10.000Z","date":"2021-03-04","kind":"exercise","acquired":true,"shares":11940,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":61231,"source":{"system":"sec-edgar","filing":"0001209191-21-018512","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121018512/doc4.xml","form_type":"4"}},{"id":2823457,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-03-02T16:04:39.000Z","date":"2021-02-28","kind":"exercise","acquired":false,"shares":19514,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 19,514 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 19,515 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 28, 2020 with 19,514 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 19,515 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":58543,"derivative":{"underlying":"Ordinary Shares","underlying_shares":19514},"source":{"system":"sec-edgar","filing":"0001209191-21-015832","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121015832/doc4.xml","form_type":"4"}},{"id":2823456,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-03-02T16:04:39.000Z","date":"2021-03-01","kind":"sale","acquired":false,"shares":9795,"price":10.8509,"value":106284.5655,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $10.775 to $11.005, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":49291,"source":{"system":"sec-edgar","filing":"0001209191-21-015832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121015832/doc4.xml","form_type":"4"}},{"id":2823455,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-03-02T16:04:39.000Z","date":"2021-02-28","kind":"exercise","acquired":true,"shares":19514,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":59086,"source":{"system":"sec-edgar","filing":"0001209191-21-015832","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121015832/doc4.xml","form_type":"4"}},{"id":2856752,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-02-17T16:06:21.000Z","date":"2021-02-14","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2020 and February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2020 and February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0001209191-21-011242","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121011242/doc4.xml","form_type":"4"}},{"id":2856751,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-02-17T16:06:21.000Z","date":"2021-02-16","kind":"sale","acquired":false,"shares":2079,"price":11.1281,"value":23135.3199,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $11.1200 to $11.1300, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":39572,"source":{"system":"sec-edgar","filing":"0001209191-21-011242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121011242/doc4.xml","form_type":"4"}},{"id":2856750,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-02-17T16:06:21.000Z","date":"2021-02-14","kind":"exercise","acquired":true,"shares":3926,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":41651,"source":{"system":"sec-edgar","filing":"0001209191-21-011242","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121011242/doc4.xml","form_type":"4"}},{"id":2867884,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-02-11T16:04:42.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":37884,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F9","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on May 11, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F9","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to\ntime-based vesting and will vest on May 11, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":37884,"derivative":{"underlying":"Ordinary Shares","underlying_shares":37884},"source":{"system":"sec-edgar","filing":"0001209191-21-009630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121009630/doc4.xml","form_type":"4"}},{"id":2867883,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2021-02-11T16:04:42.000Z","date":"2021-02-09","kind":"exercise","acquired":false,"shares":6567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Restricted share units were granted on February 9, 2018, with 6,567 vesting on each of February 9, 2020 and February 9, 2021 and 6,568 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"Restricted share units were granted on February 9, 2018, with 6,567 vesting on each of February 9, 2020 and February 9, 2021 and 6,568 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":6568,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6567},"source":{"system":"sec-edgar","filing":"0001209191-21-009630","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121009630/doc4.xml","form_type":"4"}},{"id":2867882,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-02-11T16:04:42.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":14527,"price":12.7209,"value":184796.5143,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":37725,"source":{"system":"sec-edgar","filing":"0001209191-21-009630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121009630/doc4.xml","form_type":"4"}},{"id":2867881,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-02-11T16:04:42.000Z","date":"2021-02-09","kind":"sale","acquired":false,"shares":3452,"price":12.7209,"value":43912.5468,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F5","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F6","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.635 to $12.800, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":52252,"source":{"system":"sec-edgar","filing":"0001209191-21-009630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121009630/doc4.xml","form_type":"4"}},{"id":2867880,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-02-11T16:04:42.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":27643,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"Represents ordinary shares received upon satisfaction of performance- and time-based vesting criteria of performance share units."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Each performance share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources\nand Compensation Committee, the cash value of one ordinary share."}],"balance_after":55704,"source":{"system":"sec-edgar","filing":"0001209191-21-009630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121009630/doc4.xml","form_type":"4"}},{"id":2867879,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2021-02-11T16:04:42.000Z","date":"2021-02-09","kind":"exercise","acquired":true,"shares":6567,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":28061,"source":{"system":"sec-edgar","filing":"0001209191-21-009630","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919121009630/doc4.xml","form_type":"4"}},{"id":3236280,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2020-03-03T07:10:00.000Z","date":"2020-02-28","kind":"grant","acquired":true,"shares":78057,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 19,514 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 19,515 vesting on February 28, 2024."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Restricted share units were granted on February 28, 2020 with 19,514 vesting on each of February 28, 2021, February 28, 2022 and February 28, 2023 and 19,515 vesting on February 28, 2024."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":78057,"derivative":{"underlying":"Ordinary Shares","underlying_shares":78057},"source":{"system":"sec-edgar","filing":"0001209191-20-014848","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120014848/doc4.xml","form_type":"4"}},{"id":3261081,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-20T19:17:32.000Z","date":"2020-02-19","kind":"sale","acquired":false,"shares":8000,"price":12.51,"value":100080.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":21494,"source":{"system":"sec-edgar","filing":"0001209191-20-011287","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120011287/doc4.xml","form_type":"4"}},{"id":3268620,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2020-02-18T07:22:59.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":3926,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2020 and February 14, 2021."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"Restricted share units were granted on February 14, 2017, with 3,926 vesting on each of February 14, 2020 and February 14, 2021."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":3926,"derivative":{"underlying":"Ordinary Shares","underlying_shares":3926},"source":{"system":"sec-edgar","filing":"0001209191-20-009878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009878/doc4.xml","form_type":"4"}},{"id":3268619,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2020-02-18T07:22:59.000Z","date":"2020-02-14","kind":"exercise","acquired":false,"shares":13090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 11, 2020 pursuant to the satisfaction of performance criteria and vested on February 14, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":0,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13090},"source":{"system":"sec-edgar","filing":"0001209191-20-009878","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009878/doc4.xml","form_type":"4"}},{"id":3268618,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-18T07:22:59.000Z","date":"2020-02-14","kind":"sale","acquired":false,"shares":1878,"price":12.1357,"value":22790.8446,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.12 to $12.16, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":29494,"source":{"system":"sec-edgar","filing":"0001209191-20-009878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009878/doc4.xml","form_type":"4"}},{"id":3268617,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-18T07:22:59.000Z","date":"2020-02-14","kind":"sale","acquired":false,"shares":6262,"price":12.1357,"value":75993.7534,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.12 to $12.16, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":31372,"source":{"system":"sec-edgar","filing":"0001209191-20-009878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009878/doc4.xml","form_type":"4"}},{"id":3268616,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-18T07:22:59.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":3926,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":37634,"source":{"system":"sec-edgar","filing":"0001209191-20-009878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009878/doc4.xml","form_type":"4"}},{"id":3268615,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-18T07:22:59.000Z","date":"2020-02-14","kind":"exercise","acquired":true,"shares":13090,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":33708,"source":{"system":"sec-edgar","filing":"0001209191-20-009878","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009878/doc4.xml","form_type":"4"}},{"id":3275336,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2020-02-13T07:03:06.000Z","date":"2020-02-11","kind":"grant","acquired":true,"shares":13090,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 14, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Represents restricted share units received upon satisfaction of performance criteria of performance share units. These units remain subject to time-based vesting and will vest on February 14, 2020."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F3","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13090,"derivative":{"underlying":"Ordinary Shares","underlying_shares":13090},"source":{"system":"sec-edgar","filing":"0001209191-20-009048","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120009048/doc4.xml","form_type":"4"}},{"id":3280827,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Restricted Share Units","published_at":"2020-02-11T06:56:50.000Z","date":"2020-02-09","kind":"exercise","acquired":false,"shares":6567,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 6,567 vesting on each of February 9, 2020 and February 9, 2021 and 6,568 vesting on February 9, 2022."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"Restricted share units were granted on February 9, 2018, with 6,567 vesting on each of February 9, 2020 and February 9, 2021 and 6,568 vesting on February 9, 2022."},{"field":"derivative.underlying","element":"underlyingSecurityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."}],"balance_after":13135,"derivative":{"underlying":"Ordinary Shares","underlying_shares":6567},"source":{"system":"sec-edgar","filing":"0001209191-20-008163","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120008163/doc4.xml","form_type":"4"}},{"id":3280826,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-11T06:56:50.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":3144,"price":12.2417,"value":38487.9048,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"kind","element":"transactionCoding","label":"F3","text":"The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents the number of shares required to be sold by the reporting person to cover tax withholding obligations in connection with the vesting of the restricted share units listed in Table II."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $12.2400 to $12.2450, inclusive. The reporting person undertakes to provide, upon request by the SEC staff, the issuer, or any security holder of the issuer, full information regarding the number of shares sold at each separate price."}],"balance_after":20618,"source":{"system":"sec-edgar","filing":"0001209191-20-008163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120008163/doc4.xml","form_type":"4"}},{"id":3280825,"issuer":{"id":3063,"kind":"organization","name":"TEVA PHARMACEUTICAL INDUSTRIES LTD","symbol":"TEVA"},"owners":[{"id":93402,"kind":"person","name":"Drape Eric","position":1,"cik":"0001790905","reported_name":"Drape Eric","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive VP Global Operations"}}],"security":"Ordinary Shares","published_at":"2020-02-11T06:56:50.000Z","date":"2020-02-09","kind":"exercise","acquired":true,"shares":6567,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The Ordinary Shares may be represented by American Depositary Shares, each of which currently represents one Ordinary Share."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each restricted share unit represents a contingent right to receive, at settlement, one ordinary share or, at the option of the Human Resources and Compensation Committee, the cash value of one ordinary share."}],"balance_after":23762,"source":{"system":"sec-edgar","filing":"0001209191-20-008163","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1790905/000120919120008163/doc4.xml","form_type":"4"}}]}